Imidazole derivatives, process for their preparation and their use
AssigneeTakeda Pharmaceutical Company Limited
InventorsAkihiro Tasaka, Nobuyuki Matsunaga, Akio Ojida, Masami Kusaka
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound having a steroid C17,20-lyase inhibitory activity, which is useful as a prophylactic or therapeutic agent of prostatism and tumor such as breast cancer and the like. A compound represented by the formula: 1 wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic alkyl group, and ring A and ring B are each an optionally substituted 5-membered or 6-membered ring having an amide bond in the ring, or a salt thereof.
Claims10
A compound represented by the formula:
- 76
- wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic alkyl group, and ring A and ring B are each an optionally substituted 5-membered or 6-membered ring having an amide bond in the ring, or a salt thereof.
A compound represented by the formula:
- 78
- wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic alkyl group, and R2 is a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted amino group, or a salt thereof.
A prodrug of a compound represented by the formula (Ia) or (Ib)
- 79
- wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic alkyl group, and ring A and ring B are each an optionally substituted 5-membered or 6-membered ring having an amide bond in the ring, or a salt thereof.
A pharmaceutical composition comprising a compound represented by the formula (Ia) or (Ib)
- 80
- wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic alkyl group, and ring A and ring B are each an optionally substituted 5-membered or 6-membered ring having an amide bond in the ring, or a salt thereof or a prodrug thereof.
An androgen reducer comprising a compound represented by the formula (Ia) or (Ib)
- 81
- wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic alkyl group, and ring A and ring B are each an optionally substituted 5-membered or 6-membered ring having an amide bond in the ring, or a salt thereof or a prodrug thereof, and an LHRH modulator in combination.
A production method of a compound represented by the formula:
- 82
- wherein R is a hydrogen atom or a protecting group, and R1 is a lower alkyl group or a cyclic alkyl group, or a salt thereof, which comprises reacting a compound represented by the formula:
- 83
- with a compound represented by the formula:
- 84
- wherein each symbol is as defined above, or a salt thereof, in the presence of a base.
Dependencies are inferred from the claim text.